Objective: This study assesses the performance of the Morphometric Analysis Program (MAP) in the pre- and post-surgical evaluation of pediatric patients with drug-resistant epilepsy suspected of Focal Cortical Dysplasia (FCD). We evaluated MAP-electroclinical concordance and the diagnostic contribution of individual MAP features to optimize the noninvasive presurgical assessment. Methods: After a Multidisciplinary Surgical Meeting (MSM), patients with strong electroclinical evidence of FCDs underwent MAP analysis, comparing gray/white matter distribution against a non-age-specific database. MAP results were integrated with MRI reevaluation to identify previously undetected lesions. MRI-positive patients, were analyzed for MAP-MRI-electroclinical concordance. For MRI negative patients, we assessed MAP electroclinical concordance and compared with MRI positive patients. A sub-analysis was performed in operated patients. Results: We included in the study 50 pediatric patients (age 1.5-18 y). Twenty-eight patients (56%) were MRI positive after MSM. Two patients originally classified as MRI negative were reevaluated after MAP analysis. In the MRI-positive cohort (60%, 30/50), MAP-MRI concordance was 73.3% for Prob_FCD, 80% for Junction, 63.3% for Extension, and 10% for Thickness, with electroclinical concordance reaching almost 90% for the first three features. In the MRI-negative cohort (40%, 20/50), MAP positivity rates were 10% for Prob_FCD, 40% for Junction, 85% for Extension, and 10% for Thickness. All MAP positivity in the MRI-negative group had discordant data with the electroclinical hypothesis. Significance: In our presurgical cohort, MAP enabled the identification of two previously undetected dysplastic lesions. In case of MRI+, MAP findings were mostly concordant with both MRI and the electroclinical hypothesis, with Junction as the most reliable features. In negative MRI patients, MAP positivity rarely revealed a lesion corresponding to the electroclinical hypothesis, suggesting the need for further complementary diagnostic tools to improve lesion detection and surgical planning in this subgroup.
Diagnostic performance of morphometric analysis program in pediatric epilepsy surgery / Micco, V. D.; Mercier, M.; Espagnet, C. R.; Napolitano, A.; Benedictis, A. D.; Carfi-Pavia, G.; Marras, C. E.; Vigevano, F.; De Palma, L.; Specchio, N.. - 171:(2025). [10.1016/j.yebeh.2025.110566]
Diagnostic performance of morphometric analysis program in pediatric epilepsy surgery
Mercier, M.
;
2025
Abstract
Objective: This study assesses the performance of the Morphometric Analysis Program (MAP) in the pre- and post-surgical evaluation of pediatric patients with drug-resistant epilepsy suspected of Focal Cortical Dysplasia (FCD). We evaluated MAP-electroclinical concordance and the diagnostic contribution of individual MAP features to optimize the noninvasive presurgical assessment. Methods: After a Multidisciplinary Surgical Meeting (MSM), patients with strong electroclinical evidence of FCDs underwent MAP analysis, comparing gray/white matter distribution against a non-age-specific database. MAP results were integrated with MRI reevaluation to identify previously undetected lesions. MRI-positive patients, were analyzed for MAP-MRI-electroclinical concordance. For MRI negative patients, we assessed MAP electroclinical concordance and compared with MRI positive patients. A sub-analysis was performed in operated patients. Results: We included in the study 50 pediatric patients (age 1.5-18 y). Twenty-eight patients (56%) were MRI positive after MSM. Two patients originally classified as MRI negative were reevaluated after MAP analysis. In the MRI-positive cohort (60%, 30/50), MAP-MRI concordance was 73.3% for Prob_FCD, 80% for Junction, 63.3% for Extension, and 10% for Thickness, with electroclinical concordance reaching almost 90% for the first three features. In the MRI-negative cohort (40%, 20/50), MAP positivity rates were 10% for Prob_FCD, 40% for Junction, 85% for Extension, and 10% for Thickness. All MAP positivity in the MRI-negative group had discordant data with the electroclinical hypothesis. Significance: In our presurgical cohort, MAP enabled the identification of two previously undetected dysplastic lesions. In case of MRI+, MAP findings were mostly concordant with both MRI and the electroclinical hypothesis, with Junction as the most reliable features. In negative MRI patients, MAP positivity rarely revealed a lesion corresponding to the electroclinical hypothesis, suggesting the need for further complementary diagnostic tools to improve lesion detection and surgical planning in this subgroup.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


